Blogs
Here we provide you with key information related to the Medical Device and In Vitro Diagnostic (IVD) industry through Patient Guard’s blogs. We provide invaluable content that delves into the regulation and Quality Assurance of Medical Device and IVDs, with focus on navigating the regulatory landscapes of the United Kingdom (UK), the European Union (EU), and the United States (US).
At Patient Guard, we are not just a source of information; we are your ultimate partner in understanding and maneuvering through the complexities of Medical Device and IVD regulatory requirements, as well as Quality Assurance. Our blogs serve as a beacon, illuminating the latest updates and insights crucial for professionals and organizations operating in these highly regulated sectors.
Patient Guard is not just a repository of information; we are your ally in navigating the ever-evolving landscape of Medical Device and IVD regulations. Join us on this educational journey, where compliance meets excellence.
Categories
Post-Brexit, many medical device manufacturers are still navigating the split between CE marking and the UKCA mark — and the rules keep evolving. As the MHRA advances its “future regime” for medical devices, regulatory teams face the ongoing challenge of complying with both EU MDR obligations and the UK’s own UK MDR 2002 (as amended) framework....
The newly revised ISO 10993-1:2025 has quietly done something big: it’s turned biological evaluation from a “tick-the-box biocompatibility test list” into a fully integrated risk narrative that regulators now expect to hold together scientifically, from chemistry through to clinical data.
...
After years of “coming soon”, the EU has finally put a fixed date on reality: the first EUDAMED mandatory modules must be used from 28 May 2026....
Since Brexit, appointing a UK Responsible Person (UKRP) has become a core requirement for most non-UK medical device manufacturers entering the Great Britain market. The role looks familiar (it resembles the EU Authorised Representative), but its obligations under the UK MDR 2002 (as amended) are distinct, legally binding, and far more visible to the MHRA.
...
Building an ISO 13485-compliant medical device QMS is a demanding process at the best of times — but post-MDR and UK MDR amendments have made it even tougher for resource-constrained teams. Start-ups and SMEs now face the exact regulatory expectations as global manufacturers, while juggling limited bandwidth, rapid product iterations, and aggressive investor timelines.
...
Software is now the beating heart of modern medical devices. Whether you’re building a connected inhaler, an AI-driven diagnostic tool, or an embedded control system inside a Class III device, regulators expect one thing above all: evidence that your software is safe, controlled, validated, and maintained throughout its entire lifecycle....
